img

Global Antigout Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Antigout Drug Market Insights, Forecast to 2034

Gout is a form of inflammatory arthritis characterized by recurrent attacks of a red, tender, hot, and swollen joint. Pain typically comes on rapidly in less than twelve hours.The joint at the base of the big toe is affected in about half of cases.It may also result in tophi, kidney stones, or urate nephropathy.
Global Antigout Drug market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Antigout Drug industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Antigout Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Antigout Drug market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Takeda
Aspen
heumann pharma
Teijin Pharma
Horizon Pharma
Novartis
WanBang
Jiangsu Hengrui Medicine
Rotamreddy
KPC Pharmaceuticals
Segment by Type
Febuxostat
Benzbromarone
Allopurinol
Colchicine

Segment by Application


Acute Gout
Chronic Gout

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Antigout Drug plant distribution, commercial date of Antigout Drug, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Antigout Drug introduction, etc. Antigout Drug Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Antigout Drug
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Antigout Drug Product Introduction
1.2 Market by Type
1.2.1 Global Antigout Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Febuxostat
1.2.3 Benzbromarone
1.2.4 Allopurinol
1.2.5 Colchicine
1.3 Market by Application
1.3.1 Global Antigout Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Acute Gout
1.3.3 Chronic Gout
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Antigout Drug Sales Estimates and Forecasts 2018-2029
2.2 Global Antigout Drug Revenue by Region
2.2.1 Global Antigout Drug Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Antigout Drug Revenue by Region (2018-2024)
2.2.3 Global Antigout Drug Revenue by Region (2024-2029)
2.2.4 Global Antigout Drug Revenue Market Share by Region (2018-2029)
2.3 Global Antigout Drug Sales Estimates and Forecasts 2018-2029
2.4 Global Antigout Drug Sales by Region
2.4.1 Global Antigout Drug Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Antigout Drug Sales by Region (2018-2024)
2.4.3 Global Antigout Drug Sales by Region (2024-2029)
2.4.4 Global Antigout Drug Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Antigout Drug Sales by Manufacturers
3.1.1 Global Antigout Drug Sales by Manufacturers (2018-2024)
3.1.2 Global Antigout Drug Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antigout Drug in 2022
3.2 Global Antigout Drug Revenue by Manufacturers
3.2.1 Global Antigout Drug Revenue by Manufacturers (2018-2024)
3.2.2 Global Antigout Drug Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Antigout Drug Revenue in 2022
3.3 Global Key Players of Antigout Drug, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Antigout Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Antigout Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Antigout Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Antigout Drug, Product Offered and Application
3.8 Global Key Manufacturers of Antigout Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Antigout Drug Sales by Type
4.1.1 Global Antigout Drug Historical Sales by Type (2018-2024)
4.1.2 Global Antigout Drug Forecasted Sales by Type (2024-2029)
4.1.3 Global Antigout Drug Sales Market Share by Type (2018-2029)
4.2 Global Antigout Drug Revenue by Type
4.2.1 Global Antigout Drug Historical Revenue by Type (2018-2024)
4.2.2 Global Antigout Drug Forecasted Revenue by Type (2024-2029)
4.2.3 Global Antigout Drug Revenue Market Share by Type (2018-2029)
4.3 Global Antigout Drug Price by Type
4.3.1 Global Antigout Drug Price by Type (2018-2024)
4.3.2 Global Antigout Drug Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Antigout Drug Sales by Application
5.1.1 Global Antigout Drug Historical Sales by Application (2018-2024)
5.1.2 Global Antigout Drug Forecasted Sales by Application (2024-2029)
5.1.3 Global Antigout Drug Sales Market Share by Application (2018-2029)
5.2 Global Antigout Drug Revenue by Application
5.2.1 Global Antigout Drug Historical Revenue by Application (2018-2024)
5.2.2 Global Antigout Drug Forecasted Revenue by Application (2024-2029)
5.2.3 Global Antigout Drug Revenue Market Share by Application (2018-2029)
5.3 Global Antigout Drug Price by Application
5.3.1 Global Antigout Drug Price by Application (2018-2024)
5.3.2 Global Antigout Drug Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Antigout Drug Market Size by Type
6.1.1 US & Canada Antigout Drug Sales by Type (2018-2029)
6.1.2 US & Canada Antigout Drug Revenue by Type (2018-2029)
6.2 US & Canada Antigout Drug Market Size by Application
6.2.1 US & Canada Antigout Drug Sales by Application (2018-2029)
6.2.2 US & Canada Antigout Drug Revenue by Application (2018-2029)
6.3 US & Canada Antigout Drug Market Size by Country
6.3.1 US & Canada Antigout Drug Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Antigout Drug Sales by Country (2018-2029)
6.3.3 US & Canada Antigout Drug Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Antigout Drug Market Size by Type
7.1.1 Europe Antigout Drug Sales by Type (2018-2029)
7.1.2 Europe Antigout Drug Revenue by Type (2018-2029)
7.2 Europe Antigout Drug Market Size by Application
7.2.1 Europe Antigout Drug Sales by Application (2018-2029)
7.2.2 Europe Antigout Drug Revenue by Application (2018-2029)
7.3 Europe Antigout Drug Market Size by Country
7.3.1 Europe Antigout Drug Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Antigout Drug Sales by Country (2018-2029)
7.3.3 Europe Antigout Drug Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Antigout Drug Market Size
8.1.1 China Antigout Drug Sales (2018-2029)
8.1.2 China Antigout Drug Revenue (2018-2029)
8.2 China Antigout Drug Market Size by Application
8.2.1 China Antigout Drug Sales by Application (2018-2029)
8.2.2 China Antigout Drug Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Antigout Drug Market Size by Type
9.1.1 Asia Antigout Drug Sales by Type (2018-2029)
9.1.2 Asia Antigout Drug Revenue by Type (2018-2029)
9.2 Asia Antigout Drug Market Size by Application
9.2.1 Asia Antigout Drug Sales by Application (2018-2029)
9.2.2 Asia Antigout Drug Revenue by Application (2018-2029)
9.3 Asia Antigout Drug Sales by Region
9.3.1 Asia Antigout Drug Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Antigout Drug Revenue by Region (2018-2029)
9.3.3 Asia Antigout Drug Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Antigout Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Antigout Drug Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Antigout Drug Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Antigout Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Antigout Drug Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Antigout Drug Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Antigout Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Antigout Drug Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Antigout Drug Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Antigout Drug Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Takeda
11.1.1 Takeda Company Information
11.1.2 Takeda Overview
11.1.3 Takeda Antigout Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Takeda Antigout Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Takeda Recent Developments
11.2 Aspen
11.2.1 Aspen Company Information
11.2.2 Aspen Overview
11.2.3 Aspen Antigout Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Aspen Antigout Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Aspen Recent Developments
11.3 heumann pharma
11.3.1 heumann pharma Company Information
11.3.2 heumann pharma Overview
11.3.3 heumann pharma Antigout Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 heumann pharma Antigout Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 heumann pharma Recent Developments
11.4 Teijin Pharma
11.4.1 Teijin Pharma Company Information
11.4.2 Teijin Pharma Overview
11.4.3 Teijin Pharma Antigout Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Teijin Pharma Antigout Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Teijin Pharma Recent Developments
11.5 Horizon Pharma
11.5.1 Horizon Pharma Company Information
11.5.2 Horizon Pharma Overview
11.5.3 Horizon Pharma Antigout Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Horizon Pharma Antigout Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Horizon Pharma Recent Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Overview
11.6.3 Novartis Antigout Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Novartis Antigout Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Novartis Recent Developments
11.7 WanBang
11.7.1 WanBang Company Information
11.7.2 WanBang Overview
11.7.3 WanBang Antigout Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 WanBang Antigout Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 WanBang Recent Developments
11.8 Jiangsu Hengrui Medicine
11.8.1 Jiangsu Hengrui Medicine Company Information
11.8.2 Jiangsu Hengrui Medicine Overview
11.8.3 Jiangsu Hengrui Medicine Antigout Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Jiangsu Hengrui Medicine Antigout Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Jiangsu Hengrui Medicine Recent Developments
11.9 Rotamreddy
11.9.1 Rotamreddy Company Information
11.9.2 Rotamreddy Overview
11.9.3 Rotamreddy Antigout Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Rotamreddy Antigout Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Rotamreddy Recent Developments
11.10 KPC Pharmaceuticals
11.10.1 KPC Pharmaceuticals Company Information
11.10.2 KPC Pharmaceuticals Overview
11.10.3 KPC Pharmaceuticals Antigout Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 KPC Pharmaceuticals Antigout Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 KPC Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Antigout Drug Industry Chain Analysis
12.2 Antigout Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antigout Drug Production Mode & Process
12.4 Antigout Drug Sales and Marketing
12.4.1 Antigout Drug Sales Channels
12.4.2 Antigout Drug Distributors
12.5 Antigout Drug Customers
13 Market Dynamics
13.1 Antigout Drug Industry Trends
13.2 Antigout Drug Market Drivers
13.3 Antigout Drug Market Challenges
13.4 Antigout Drug Market Restraints
14 Key Findings in The Global Antigout Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Antigout Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Febuxostat
Table 3. Major Manufacturers of Benzbromarone
Table 4. Major Manufacturers of Allopurinol
Table 5. Major Manufacturers of Colchicine
Table 6. Global Antigout Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Antigout Drug Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Antigout Drug Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Antigout Drug Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Antigout Drug Revenue Market Share by Region (2018-2024)
Table 11. Global Antigout Drug Revenue Market Share by Region (2024-2029)
Table 12. Global Antigout Drug Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Antigout Drug Sales by Region (2018-2024) & (K Units)
Table 14. Global Antigout Drug Sales by Region (2024-2029) & (K Units)
Table 15. Global Antigout Drug Sales Market Share by Region (2018-2024)
Table 16. Global Antigout Drug Sales Market Share by Region (2024-2029)
Table 17. Global Antigout Drug Sales by Manufacturers (2018-2024) & (K Units)
Table 18. Global Antigout Drug Sales Share by Manufacturers (2018-2024)
Table 19. Global Antigout Drug Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Antigout Drug Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Antigout Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Antigout Drug Price by Manufacturers 2018-2024 (USD/Unit)
Table 23. Global Antigout Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Antigout Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antigout Drug as of 2022)
Table 25. Global Key Manufacturers of Antigout Drug, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Antigout Drug, Product Offered and Application
Table 27. Global Key Manufacturers of Antigout Drug, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Antigout Drug Sales by Type (2018-2024) & (K Units)
Table 30. Global Antigout Drug Sales by Type (2024-2029) & (K Units)
Table 31. Global Antigout Drug Sales Share by Type (2018-2024)
Table 32. Global Antigout Drug Sales Share by Type (2024-2029)
Table 33. Global Antigout Drug Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Antigout Drug Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Antigout Drug Revenue Share by Type (2018-2024)
Table 36. Global Antigout Drug Revenue Share by Type (2024-2029)
Table 37. Antigout Drug Price by Type (2018-2024) & (USD/Unit)
Table 38. Global Antigout Drug Price Forecast by Type (2024-2029) & (USD/Unit)
Table 39. Global Antigout Drug Sales by Application (2018-2024) & (K Units)
Table 40. Global Antigout Drug Sales by Application (2024-2029) & (K Units)
Table 41. Global Antigout Drug Sales Share by Application (2018-2024)
Table 42. Global Antigout Drug Sales Share by Application (2024-2029)
Table 43. Global Antigout Drug Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Antigout Drug Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Antigout Drug Revenue Share by Application (2018-2024)
Table 46. Global Antigout Drug Revenue Share by Application (2024-2029)
Table 47. Antigout Drug Price by Application (2018-2024) & (USD/Unit)
Table 48. Global Antigout Drug Price Forecast by Application (2024-2029) & (USD/Unit)
Table 49. US & Canada Antigout Drug Sales by Type (2018-2024) & (K Units)
Table 50. US & Canada Antigout Drug Sales by Type (2024-2029) & (K Units)
Table 51. US & Canada Antigout Drug Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Antigout Drug Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Antigout Drug Sales by Application (2018-2024) & (K Units)
Table 54. US & Canada Antigout Drug Sales by Application (2024-2029) & (K Units)
Table 55. US & Canada Antigout Drug Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Antigout Drug Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Antigout Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Antigout Drug Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Antigout Drug Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Antigout Drug Sales by Country (2018-2024) & (K Units)
Table 61. US & Canada Antigout Drug Sales by Country (2024-2029) & (K Units)
Table 62. Europe Antigout Drug Sales by Type (2018-2024) & (K Units)
Table 63. Europe Antigout Drug Sales by Type (2024-2029) & (K Units)
Table 64. Europe Antigout Drug Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Antigout Drug Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Antigout Drug Sales by Application (2018-2024) & (K Units)
Table 67. Europe Antigout Drug Sales by Application (2024-2029) & (K Units)
Table 68. Europe Antigout Drug Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Antigout Drug Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Antigout Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Antigout Drug Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Antigout Drug Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Antigout Drug Sales by Country (2018-2024) & (K Units)
Table 74. Europe Antigout Drug Sales by Country (2024-2029) & (K Units)
Table 75. China Antigout Drug Sales by Type (2018-2024) & (K Units)
Table 76. China Antigout Drug Sales by Type (2024-2029) & (K Units)
Table 77. China Antigout Drug Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Antigout Drug Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Antigout Drug Sales by Application (2018-2024) & (K Units)
Table 80. China Antigout Drug Sales by Application (2024-2029) & (K Units)
Table 81. China Antigout Drug Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Antigout Drug Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Antigout Drug Sales by Type (2018-2024) & (K Units)
Table 84. Asia Antigout Drug Sales by Type (2024-2029) & (K Units)
Table 85. Asia Antigout Drug Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Antigout Drug Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Antigout Drug Sales by Application (2018-2024) & (K Units)
Table 88. Asia Antigout Drug Sales by Application (2024-2029) & (K Units)
Table 89. Asia Antigout Drug Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Antigout Drug Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Antigout Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Antigout Drug Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Antigout Drug Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Antigout Drug Sales by Region (2018-2024) & (K Units)
Table 95. Asia Antigout Drug Sales by Region (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Antigout Drug Sales by Type (2018-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Antigout Drug Sales by Type (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Antigout Drug Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Antigout Drug Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Antigout Drug Sales by Application (2018-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Antigout Drug Sales by Application (2024-2029) & (K Units)
Table 102. Middle East, Africa and Latin America Antigout Drug Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Antigout Drug Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Antigout Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Antigout Drug Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Antigout Drug Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Antigout Drug Sales by Country (2018-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Antigout Drug Sales by Country (2024-2029) & (K Units)
Table 109. Takeda Company Information
Table 110. Takeda Description and Major Businesses
Table 111. Takeda Antigout Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 112. Takeda Antigout Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Takeda Recent Developments
Table 114. Aspen Company Information
Table 115. Aspen Description and Major Businesses
Table 116. Aspen Antigout Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 117. Aspen Antigout Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Aspen Recent Developments
Table 119. heumann pharma Company Information
Table 120. heumann pharma Description and Major Businesses
Table 121. heumann pharma Antigout Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 122. heumann pharma Antigout Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. heumann pharma Recent Developments
Table 124. Teijin Pharma Company Information
Table 125. Teijin Pharma Description and Major Businesses
Table 126. Teijin Pharma Antigout Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 127. Teijin Pharma Antigout Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Teijin Pharma Recent Developments
Table 129. Horizon Pharma Company Information
Table 130. Horizon Pharma Description and Major Businesses
Table 131. Horizon Pharma Antigout Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 132. Horizon Pharma Antigout Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Horizon Pharma Recent Developments
Table 134. Novartis Company Information
Table 135. Novartis Description and Major Businesses
Table 136. Novartis Antigout Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 137. Novartis Antigout Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Novartis Recent Developments
Table 139. WanBang Company Information
Table 140. WanBang Description and Major Businesses
Table 141. WanBang Antigout Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 142. WanBang Antigout Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. WanBang Recent Developments
Table 144. Jiangsu Hengrui Medicine Company Information
Table 145. Jiangsu Hengrui Medicine Description and Major Businesses
Table 146. Jiangsu Hengrui Medicine Antigout Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 147. Jiangsu Hengrui Medicine Antigout Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Jiangsu Hengrui Medicine Recent Developments
Table 149. Rotamreddy Company Information
Table 150. Rotamreddy Description and Major Businesses
Table 151. Rotamreddy Antigout Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 152. Rotamreddy Antigout Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Rotamreddy Recent Developments
Table 154. KPC Pharmaceuticals Company Information
Table 155. KPC Pharmaceuticals Description and Major Businesses
Table 156. KPC Pharmaceuticals Antigout Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 157. KPC Pharmaceuticals Antigout Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. KPC Pharmaceuticals Recent Developments
Table 159. Key Raw Materials Lists
Table 160. Raw Materials Key Suppliers Lists
Table 161. Antigout Drug Distributors List
Table 162. Antigout Drug Customers List
Table 163. Antigout Drug Market Trends
Table 164. Antigout Drug Market Drivers
Table 165. Antigout Drug Market Challenges
Table 166. Antigout Drug Market Restraints
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Antigout Drug Product Picture
Figure 2. Global Antigout Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Antigout Drug Market Share by Type in 2022 & 2029
Figure 4. Febuxostat Product Picture
Figure 5. Benzbromarone Product Picture
Figure 6. Allopurinol Product Picture
Figure 7. Colchicine Product Picture
Figure 8. Global Antigout Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Antigout Drug Market Share by Application in 2022 & 2029
Figure 10. Acute Gout
Figure 11. Chronic Gout
Figure 12. Antigout Drug Report Years Considered
Figure 13. Global Antigout Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Antigout Drug Revenue 2018-2029 (US$ Million)
Figure 15. Global Antigout Drug Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Antigout Drug Revenue Market Share by Region (2018-2029)
Figure 17. Global Antigout Drug Sales 2018-2029 ((K Units)
Figure 18. Global Antigout Drug Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Antigout Drug Sales YoY (2018-2029) & (K Units)
Figure 20. US & Canada Antigout Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Antigout Drug Sales YoY (2018-2029) & (K Units)
Figure 22. Europe Antigout Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Antigout Drug Sales YoY (2018-2029) & (K Units)
Figure 24. China Antigout Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Antigout Drug Sales YoY (2018-2029) & (K Units)
Figure 26. Asia (excluding China) Antigout Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Antigout Drug Sales YoY (2018-2029) & (K Units)
Figure 28. Middle East, Africa and Latin America Antigout Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Antigout Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Antigout Drug in the World: Market Share by Antigout Drug Revenue in 2022
Figure 31. Global Antigout Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Antigout Drug Sales Market Share by Type (2018-2029)
Figure 33. Global Antigout Drug Revenue Market Share by Type (2018-2029)
Figure 34. Global Antigout Drug Sales Market Share by Application (2018-2029)
Figure 35. Global Antigout Drug Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Antigout Drug Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Antigout Drug Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Antigout Drug Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Antigout Drug Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Antigout Drug Revenue Share by Country (2018-2029)
Figure 41. US & Canada Antigout Drug Sales Share by Country (2018-2029)
Figure 42. U.S. Antigout Drug Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Antigout Drug Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Antigout Drug Sales Market Share by Type (2018-2029)
Figure 45. Europe Antigout Drug Revenue Market Share by Type (2018-2029)
Figure 46. Europe Antigout Drug Sales Market Share by Application (2018-2029)
Figure 47. Europe Antigout Drug Revenue Market Share by Application (2018-2029)
Figure 48. Europe Antigout Drug Revenue Share by Country (2018-2029)
Figure 49. Europe Antigout Drug Sales Share by Country (2018-2029)
Figure 50. Germany Antigout Drug Revenue (2018-2029) & (US$ Million)
Figure 51. France Antigout Drug Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Antigout Drug Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Antigout Drug Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Antigout Drug Revenue (2018-2029) & (US$ Million)
Figure 55. China Antigout Drug Sales Market Share by Type (2018-2029)
Figure 56. China Antigout Drug Revenue Market Share by Type (2018-2029)
Figure 57. China Antigout Drug Sales Market Share by Application (2018-2029)
Figure 58. China Antigout Drug Revenue Market Share by Application (2018-2029)
Figure 59. Asia Antigout Drug Sales Market Share by Type (2018-2029)
Figure 60. Asia Antigout Drug Revenue Market Share by Type (2018-2029)
Figure 61. Asia Antigout Drug Sales Market Share by Application (2018-2029)
Figure 62. Asia Antigout Drug Revenue Market Share by Application (2018-2029)
Figure 63. Asia Antigout Drug Revenue Share by Region (2018-2029)
Figure 64. Asia Antigout Drug Sales Share by Region (2018-2029)
Figure 65. Japan Antigout Drug Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Antigout Drug Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Antigout Drug Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Antigout Drug Revenue (2018-2029) & (US$ Million)
Figure 69. India Antigout Drug Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Antigout Drug Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Antigout Drug Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Antigout Drug Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Antigout Drug Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Antigout Drug Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Antigout Drug Sales Share by Country (2018-2029)
Figure 76. Brazil Antigout Drug Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Antigout Drug Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Antigout Drug Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Antigout Drug Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Antigout Drug Revenue (2018-2029) & (US$ Million)
Figure 81. Antigout Drug Value Chain
Figure 82. Antigout Drug Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries